Document ID: FDA-2011-N-0002-0031
Agency: fda
Document Type: Notice
Title: Meetings: Preparation for International Cooperation on Cosmetics Regulations
Posted Date: 2011-04-05T04:00Z

[Federal Register Volume 76, Number 65 (Tuesday, April 5, 2011)]
[Notices]
[Pages 18767-18768]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-7966]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2011-N-0002]

Preparation for International Cooperation on Cosmetics 
Regulations; Public Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing a public 
meeting entitled ``International Cooperation on Cosmetics Regulations 
(ICCR)--Preparation for ICCR-5 Meeting in Paris, France'' to provide 
information and receive comments on the International Cooperation on 
Cosmetics Regulations (ICCR) as well as the upcoming meetings in Paris, 
France. The topics to be discussed are the topics for discussion at the 
forthcoming ICCR Steering Committee meeting. The purpose of the meeting 
is to solicit public input prior to the next steering committee and 
expert working group meetings in Paris, France scheduled on June 28 
through July 1, 2011.

DATES:  Date and Time: The public meeting will be held on April 26, 
2011, from 2 p.m. to 4 p.m.
    Location: The public meeting will be held at the Washington Theater 
room at the Hilton Washington DC/Rockville Hotel & Executive Meeting 
Center, 1750 Rockville Pike, Rockville, MD 20852.
    Contact Person: All participants must register with Kimberly 
Franklin, Office of the Commissioner, Food and Drug Administration, 
10903 New Hampshire Ave., Silver Spring, MD 20993-0002, e-mail: 
Kimberly.Franklin@fda.hhs.gov, or Fax: 301-595-7937.
    Registration and Requests for Oral Presentations: Send registration 
information (including name, title, firm name, address, telephone, and 
fax number), written material, and requests to make oral presentations, 
to the contact person by April 22, 2011.
    If you need special accommodations due to a disability, please 
contact Kimberly Franklin (see Contact Person) at least 7 days in 
advance.
    Interested persons may present data, information, or views orally 
or in writing, on issues pending at the public meeting. Time allotted 
for oral presentations may be limited to 10 minutes. Those desiring to 
make oral presentations should notify the contact person by April 22, 
2011, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses, 
telephone number, fax, and e-mail of proposed participants, and an 
indication of the approximate time requested to make their 
presentation.
    Transcripts: Please be advised that as soon as a transcript is 
available, it will be accessible at http://www.regulations.gov. It may 
be viewed at the Division of Dockets Management (HFA-305), Food and 
Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD. A 
transcript will also be available in either hardcopy or on CD-ROM, 
after submission of a Freedom of Information request. Written requests 
are to be sent to Division of Freedom of Information, 12420 Parklawn 
Dr., Rockville, MD 20857.

SUPPLEMENTARY INFORMATION: The purpose of the multilateral framework on 
the ICCR is to pave the way for the removal of regulatory obstacles to 
international trade while maintaining global consumer protection.
    ICCR is a voluntary international group of cosmetics regulatory 
authorities from the United States, Japan, the European Union, and 
Canada. These regulatory authority members will enter into constructive 
dialogue with their relevant cosmetics' industry trade associations. 
Currently, the ICCR members are Health Canada; the European Directorate 
General for Enterprise and Industry; the Ministry of Health, Labor and 
Welfare of Japan; and the U.S. Food and Drug Administration. All 
decisions made by the consensus will be compatible with the laws, 
policies, rules, regulations, and directives of the respective 
administrations and governments. Members will implement and/or

[[Page 18768]]

promote actions or documents within their own jurisdictions and seek 
convergence of regulatory policies and practices. Successful 
implementation will require input from stakeholders.
    The agenda for the public meeting will be made available on the 
Internet at http://www.fda.gov/Cosmetics/InternationalActivities/ConferencesMeetingsWorkshops/InternationalCooperationonCosmeticsRegulationsICCR/default.htm.

    Dated: March 30, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011-7966 Filed 4-4-11; 8:45 am]
BILLING CODE 4160-01-P